Author:
Keating Gillian M.,Dhillon Sohita
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference15 articles.
1. Dhillon S. Octocog alfa, antihaemophilic factor (recombinant), plasma/albumin free method (Advate®): a review of its use in the management of patients wtih haemophilia A. Drugs 2012; 72(7): 987–1007
2. Advate: summary of product characteristics. London: European Medicines Agency, 2012 Mar 2
3. Antihaemophilic factor (recombinant), plasma/albumin-free method (Advate): US prescribing information. Westlake Village (CA): Baxter Healthcare Corporation, 2011 Dec
4. Tarantino MD, Collins PW, Hay CR, et al. Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albuminfree method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A. Haemophilia 2004 Sep; 10(5): 428–37
5. Shapiro AD. Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of haemophilia A. Vasc Health Risk Manag 2007; 3(5): 555–65
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献